Enhancing anticancer efficacy: xovoltib-loaded chitosan-tripolyphosphate nanoparticles for targeted drug delivery against MCF-7 breast cancer cells
Source abstract
Abstract
The objective of this study is to obtain precise medication delivery by combining the drug xovoltib with chitosan nanoparticles that are synthesized from the cuttlebone of sepia. The effectiveness of this drug delivery system will be evaluated by examining its ability to inhibit the growth of cancer cells using the MCF-7 cell line. This study synthesized chitosan from the cuttlebone of sepia and complexed it with Tri Polyphosphate to form Chitosan-Tri Poly phosphate-nanoparticles (CS-TPP-NPS) using the ionotropic gelation method. The UV-visible absorption study showed a strong characteristic band ranging between 200–800 nm. The 2θ value at 20.0 degrees and 20.63 degrees indicates the crystalline nature of CS-TPP-NPS loaded with xovoltib. HR-SEM image but the morphology of chitosan nanoparticles was magnified with a high voltage of 20,000 KV and observed as spherical, porous and smooth. The in vitro drug delivery of xovoltib-loaded CS-TPP was tested against MCF-7 which had lowered the cell viability rate at 300 µl/mL.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Nanoplatforms for cancer theranostics · Dendrimers and Hyperbranched Polymers
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
PG & Research, Department of Advanced Zoology and Biotechnology, Loyola College, Chennai, India
Department of Physics and Astronomy, College of Science, King Saud University, Riyadh, Saudi Arabia
Department of Environmental Biology, Sapienza University of Rome, Rome, Italy
Department of Pharmacology, Saveetha Dental College, Saveetha Institute of Medical and Technical Sciences (SIMATS), Chennai, India
Department of Medical Microbiology and Immunology, Institute of Biomedical Science, Mekelle University, Mekelle, Ethiopia
References (42)
Show source-provided references
1. 10.1083/jcb.20091010410.1083/jcb.200910104 ↗
2. Lasfargues EY, Ozello L. Cultivation of human breast carcinomas. J Natl Cancer Inst. 1958;21:1131–1147.
3. 10.1007/BF0261612010.1007/BF02616120 ↗
4. 10.1093/jnci/51.5.140910.1093/jnci/51.5.1409 ↗
5. Levvenson SA, Jordan VC. T-cell recognition of tumor-associated carbohydrates: the nature of the glycan moiety plays a decisive role in determining glycopeptide immunogenicity. Perspectives Cancer Res. 1997;57(15):-3071–3078.
6. Agarwal M, Nagar DP, Srivastava N, et al. Chitosan nanoparticles based drug delivery. Int J Adv Multidiscip Res. 2015;2(4):-1–13.
7. 10.1016/j.ijbiomac.2023.12412010.1016/j.ijbiomac.2023.124120 ↗
8. Aruna U, Rajalakshmi R, Muzib IY, et al. Role of chitosan nanoparticles in cancer therapy. Int J Innovative Pharm Res. 2013;4(3):318–324.
9. Zhou SH, Hong Y, Fang GJ. Preparation, characterization and anticancer effect of chitosan naaoparticles. J Clin Rehabilitative Tissue Eng Resource. 2007;111(48):9688–9691.
10. Fang GJ, Hong Y, Jiang YY. Comparision of antitumor effects of chitosan nanoparticles from different sourse invitro. J Clin Rehabilitative Tissue Eng Resource. 2007;11(48):9696–9699.
11. 10.1038/s41598-020-76015-310.1038/s41598-020-76015-3 ↗
12. 10.1002/jcp.2926510.1002/jcp.29265 ↗
13. 10.1002/mabi.20210000510.1002/mabi.202100005 ↗
14. 10.1038/nrd108810.1038/nrd1088 ↗
15. 10.1007/978-3-662-03680-8_410.1007/978-3-662-03680-8_4 ↗
16. 10.2174/138161282266616041812170010.2174/1381612822666160418121700 ↗
17. 10.1016/j.addr.2009.11.00910.1016/j.addr.2009.11.009 ↗
18. 10.1155/2019/275138410.1155/2019/2751384 ↗
19. 10.2217/nnm.12.8710.2217/nnm.12.87 ↗
20. Lam TD, Hoang VD, Lien LN, et al. Synthesis and characterization of chitosan nanoparticles used as drug. J Chem. 2006;44:105–109.
21. 10.3329/icpj.v1i9.1161610.3329/icpj.v1i9.11616 ↗
22. 10.3390/polym1208179210.3390/polym12081792 ↗
23. 10.1016/j.flm.2018.07.00310.1016/j.flm.2018.07.003 ↗
24. 10.1007/s10876-019-01601-z10.1007/s10876-019-01601-z ↗
25. Mohammed SSS, Lawrance AV, Sampath S, et al. Facile green synthesis of silver nanoparticles from sprouted zingiberaceae species: spectral characterisation and its potential biological applications. Mater Technol. 2020;37(8):533–546.
26. 10.1080/10667857.2023.226935810.1080/10667857.2023.2269358 ↗
27. 10.1007/s13399-023-04127-710.1007/s13399-023-04127-7 ↗
28. Yasasve M, Kumaran PM, Manoj D, et al. Evaluation of arjunolic acid against brucella melitenis and in vitro cytotoxic study of lung adenocarcinomic cell line (A549). Indian J Exp Biol (IJEB). 2022;60:510–513.
29. 10.1016/j.fct.2008.04.01010.1016/j.fct.2008.04.010 ↗
30. 10.1016/0022-1759(83)90303-410.1016/0022-1759(83)90303-4 ↗
31. How to cite IBM SPSS statistics or earlier versions of SPSS [Internet]. [cited 2022 Jun 10]. Available from: https://www.ibm.com/support/pages/how-cite-ibm-spss-statistics-or-earlier-versions-spss
32. Wang SL, Chang TJ, Liang TW. Conversion and degradation of shellfish wastes by serratia species. TKU016 fermentation for the production of enzymes and bioactive materials. Biodegradation. 2010;10532:009–9303.
33. 10.3390/ma1522796910.3390/ma15227969 ↗
34. 10.1016/j.bcdf.2015.09.00310.1016/j.bcdf.2015.09.003 ↗
35. 10.1016/j.foodchem.2013.03.09810.1016/j.foodchem.2013.03.098 ↗
36. 10.3109/07388551.2013.79825610.3109/07388551.2013.798256 ↗
37. 10.3390/polym1311171710.3390/polym13111717 ↗
38. 10.7314/APJCP.2016.17.4.227710.7314/APJCP.2016.17.4.2277 ↗
39. 10.1002/jbm.b.3008110.1002/jbm.b.30081 ↗
40. 10.1016/j.matchemphys.2008.11.00910.1016/j.matchemphys.2008.11.009 ↗
41. 10.1007/s00436-015-4837-910.1007/s00436-015-4837-9 ↗
42. Garcia R, Franklin RA, McCubrey JA. Cell death of MCF-7 human breast cancer cell induced by EGFR activation in the absence of other growth factors. Cell Cycle. 2006;5(16):-1840–1846.